Published in Br J Clin Pharmacol on February 01, 1985
Use of check lists in assessing the statistical content of medical studies. Br Med J (Clin Res Ed) (1986) 7.42
Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ (2006) 1.89
READER: an acronym to aid critical reading by general practitioners. Br J Gen Pract (1994) 1.26
Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products. BMC Complement Altern Med (2009) 0.83
Computers working for medicine. Br J Clin Pharmacol (1985) 0.75
Statistical evaluation of medical journal manuscripts. JAMA (1966) 6.37
A METHOD FOR THE ASSESSMENT OF REPORTS OF DRUG TRIALS. Can Med Assoc J (1964) 5.13
Reporting on methods in clinical trials. N Engl J Med (1982) 3.98
Observation and experiment. N Engl J Med (1953) 3.53
Assessing reports of therapeutic trials. Br Med J (1970) 3.44
Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. Br Med J (1977) 3.08
Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J (Clin Res Ed) (1981) 3.08
Statistical errors in papers in the British Journal of Psychiatry. Br J Psychiatry (1979) 2.38
Statistics and ethics in medical research. Misuse of statistics is unethical. Br Med J (1980) 2.02
Is the statistical assessment of papers submitted to the "British Medical Journal" effective? Br Med J (Clin Res Ed) (1983) 1.92
A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med (1969) 1.42
Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities. Eur J Clin Pharmacol (1981) 0.90
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Diagnostic tests 2: Predictive values. BMJ (1994) 12.97
Diagnostic tests. 1: Sensitivity and specificity. BMJ (1994) 11.35
Simple sample size calculation for cluster-randomized trials. Int J Epidemiol (1999) 10.46
Absence of evidence is not evidence of absence. BMJ (1995) 10.36
Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (1998) 9.32
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
Unemployment and mortality in the OPCS Longitudinal Study. Lancet (1984) 7.44
Statistics notes: the normal distribution. BMJ (1995) 6.82
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Empirical assessment of effect of publication bias on meta-analyses. BMJ (2000) 5.96
Comparison of clinical information gained from routine blood-gas analysis and from gastric tonometry for intramural pH. Lancet (1993) 5.90
Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ (1999) 5.86
Simultaneous inference in epidemiological studies. Int J Epidemiol (1982) 5.77
Visual problems in the elderly population and implications for services. BMJ (1992) 5.67
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Social class mortality differentials: artefact, selection or life circumstances? J Epidemiol Community Health (1985) 5.55
Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41
How to randomise. BMJ (1999) 5.24
Air pollution and daily mortality in London: 1987-92. BMJ (1996) 4.97
Comparing several groups using analysis of variance. BMJ (1996) 4.89
General practitioner and health promotion: what patients think. Br Med J (Clin Res Ed) (1984) 4.79
Are general practitioners doing enough to promote healthy lifestyle? Findings of the Medical Research Council's general practice research framework study on lifestyle and health. Br Med J (Clin Res Ed) (1987) 4.48
Time to event (survival) data. BMJ (1998) 4.29
The natural history of asthma in childhood. J Epidemiol Community Health (1986) 4.09
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
The intracluster correlation coefficient in cluster randomisation. BMJ (1998) 4.07
Unemployment and mortality: further evidence from the OPCS Longitudinal Study 1971-81. Lancet (1986) 4.03
Unemployment and mortality: comparison of the 1971 and 1981 longitudinal study census samples. Br Med J (Clin Res Ed) (1987) 3.93
Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. BMJ (1989) 3.83
The development of respiratory symptoms in a cohort of Kent schoolchildren. Bull Physiopathol Respir (Nancy) (1975) 3.78
Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J (1988) 3.77
Diagnostic tests 3: receiver operating characteristic plots. BMJ (1994) 3.73
Analysis of survival data by the proportional odds model. Stat Med (1984) 3.70
Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet (2008) 3.65
Using data from the 1991 census. BMJ (1995) 3.63
Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth (2002) 3.60
Surgery on the rheumatoid cervical spine for the non-ambulant myelopathic patient-too much, too late? Lancet (1996) 3.52
Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31
A trial of artemether or quinine in children with cerebral malaria. N Engl J Med (1996) 3.28
Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25
Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet (1995) 3.20
Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19
Meiotic pachytene arrest in MLH1-deficient mice. Cell (1996) 3.18
Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14
Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ (1999) 3.12
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
High incidence of malaria in alpha-thalassaemic children. Nature (1996) 3.12
Crop management and agronomic context of the Farm Scale Evaluations of genetically modified herbicide-tolerant crops. Philos Trans R Soc Lond B Biol Sci (2003) 3.12
Incidence of pregnancy after laparoscopy and hydrotubation. Br Med J (Clin Res Ed) (1982) 3.11
Analysis of a trial randomised in clusters. BMJ (1998) 3.10
Loss of employment and mortality. BMJ (1994) 3.06
Detection and management of hypertension in general practices in north west London. Br Med J (Clin Res Ed) (1984) 3.04
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J (1979) 2.98
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol (2005) 2.97
Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90
Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90
Detecting skewness from summary information. BMJ (1996) 2.88
A hazard of modern life... Lancet (1983) 2.87
Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85
Population-based distributions of haemostatic variables. Br Med Bull (1977) 2.83
Sample size in cluster randomisation. BMJ (1998) 2.82
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Quartiles, quintiles, centiles, and other quantiles. BMJ (1994) 2.68
Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65
Accreditation in transoesophageal echocardiography: statement from the Association of Cardiothoracic Anaesthetists and the British Society of Echocardiography Joint TOE Accreditation Committee. Br J Anaesth (2003) 2.64
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
Factors associated with the starting of cigarette smoking by primary school children. Br J Prev Soc Med (1974) 2.61
A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol (2002) 2.57
Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57
Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56
Long-term study of smoking by secondary schoolchildren. Arch Dis Child (1978) 2.54
Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ (1995) 2.54
Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51
Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45
Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet (2008) 2.42
Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother (1993) 2.40
Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res (2000) 2.36
Quality of life measures in health care. III: Resource allocation. BMJ (1992) 2.31
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation (1979) 2.30
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Physiology of diving of birds and mammals. Physiol Rev (1997) 2.26
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. BMJ (1992) 2.26
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
Bereavement and cancer: some data on deaths of spouses from the longitudinal study of Office of Population Censuses and Surveys. Br Med J (Clin Res Ed) (1984) 2.16
Academic performance and social factors related to cigarette smoking by schoolchildren. Br J Prev Soc Med (1977) 2.15
Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. BJU Int (1999) 2.14
Bayesian methods in health technology assessment: a review. Health Technol Assess (2000) 2.14
Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J (1998) 2.13